333 LAKESIDE DR, FOSTER CITY, CA
Annual Report to Security Holders
Sciences to Acquire to Maximize Long-Term Potential of Anito-cel
Announces Fourth Quarter and Full Year 2025 Financial Results
Executive Departure - Deborah H. Telman Exits Gilead Sciences
Announces Third Quarter 2025 Financial Results
News
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Announces Second Quarter 2025 Financial Results
FY 2024
Q3
Q2
Q1
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
Additional Proxy Soliciting Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Amended Tender Offer Statement by Third Party